The Institutional Review Board (IRB) at GBMC is responsible for protecting the rights and welfare of human subjects participating in research at GBMC.
GBMC requires all proposed research that involves intervention with human subjects, identifiable private data in medical records and data collection/analysis be reviewed and approved by the IRB. The IRB monitors human subject research to determine that it is conducted ethically and in compliance with federal regulations, state laws and GBMC policies and procedures.
The function of the IRB is federally-mandated and is regulated by the Department of Health and Human Services (45 CFR 46) and the Food and Drug Administration (21 CFR 50 and 56).
GBMC maintains an assurance of compliance, called a Federalwide Assurance (FWA), with the Office for Human Research Protections (OHRP) in the U.S. Department of Health and Human Services (HHS).
All Institutional Review Boards designated in an FWA must be registered with the U.S. Department Health and Human Services (HHS). The IRB at GBMC is registered with the HHS.
The GBMC IRB is comprised of highly qualified members with varying backgrounds. The membership includes a chairperson, two vice-chairpersons and representatives from the medical staff, pharmacy, legal affairs, nursing, and the community.
The IRB meets every third Monday of the month at 5:00 p.m. in the GBMC Physicians Pavilion East Conference Center. View the Meeting Dates and Submission Deadlines.
GBMC uses IRBNet for the electronic administration and management of its IRB. All research projects submitted for review by the IRB must be sent electronically through IRBNet. Paper submissions are not accepted.
If you are a GBMC affiliated researcher interested in submitting a research project to the IRB, please refer to the Institutional Review Board Menu on the left side of this screen and “IRBNet Access and Training”.
IRB Coordinator
Email: cdemmitt@gbmc.org
Phone: 443-849-2379
Martha McCracken
IRB Assistant
Email: mmccrack@gbmc.org
Phone: 443-849-3120
Office Fax Number: 443-849-4199
GBMC requires all proposed research that involves intervention with human subjects, identifiable private data in medical records and data collection/analysis be reviewed and approved by the IRB. The IRB monitors human subject research to determine that it is conducted ethically and in compliance with federal regulations, state laws and GBMC policies and procedures.
The function of the IRB is federally-mandated and is regulated by the Department of Health and Human Services (45 CFR 46) and the Food and Drug Administration (21 CFR 50 and 56).
GBMC maintains an assurance of compliance, called a Federalwide Assurance (FWA), with the Office for Human Research Protections (OHRP) in the U.S. Department of Health and Human Services (HHS).
FWA Number | Expiration Date |
FWA00003849 | July 25, 2022 |
All Institutional Review Boards designated in an FWA must be registered with the U.S. Department Health and Human Services (HHS). The IRB at GBMC is registered with the HHS.
Registration Number | Expiration Date |
IRB00002961 | July 7, 2023 |
The GBMC IRB is comprised of highly qualified members with varying backgrounds. The membership includes a chairperson, two vice-chairpersons and representatives from the medical staff, pharmacy, legal affairs, nursing, and the community.
The IRB meets every third Monday of the month at 5:00 p.m. in the GBMC Physicians Pavilion East Conference Center. View the Meeting Dates and Submission Deadlines.
GBMC uses IRBNet for the electronic administration and management of its IRB. All research projects submitted for review by the IRB must be sent electronically through IRBNet. Paper submissions are not accepted.
If you are a GBMC affiliated researcher interested in submitting a research project to the IRB, please refer to the Institutional Review Board Menu on the left side of this screen and “IRBNet Access and Training”.
For further information, contact the IRB staff:
Cathy DemmittIRB Coordinator
Email: cdemmitt@gbmc.org
Phone: 443-849-2379
Martha McCracken
IRB Assistant
Email: mmccrack@gbmc.org
Phone: 443-849-3120
Office Fax Number: 443-849-4199
IMPORTANT Visitor Policy Changes
Recent Stories | Video | In the Media

GBMC Achieves the Prestigious Malcolm Baldrige National Quality Award
Awards
A Special Conversation with Dr. Freeman Hrabowski and Mrs. Jacqueline Hrabowski
Around GBMC
February 18: COVID-19 Update with President and CEO, John B. Chessare, MD, MPH
COVID-19
Midday Maryland - Mask Wearing and Hearing Impairment
Healthy Tips
OPINION: The Deafening Silence of the NFL, Their Players, and Domestic Violence
Family Focus
February 4: COVID-19 Update with President and CEO, John B. Chessare, MD, MPH
COVID-19
What You Need to Know About the COVID-19 Vaccines
COVID-19
GBMC's COVID-19 Vaccine Rollout
COVID-19
Discussing the Impacts of COVID-19 on Children
COVID-19
Treating and Defeating COVID-19
COVID-19
What Receiving the COVID-19 Vaccine is Like
COVID-19
Midday Maryland - Cervical Cancer
Healthy Tips
January 21: COVID-19 Update with President and CEO, John B. Chessare, MD, MPH
COVID-19
"What's Up, Dr. Dovec?" - Meet JoAnn Ioannou, DNP, MBA, RN, NEA-BC
Around GBMC
"What's Up, Dr. Dovec?" - Meet Dr. Diana Whitehead, discussing Gastroenterology at GBMC
Around GBMC
"What's Up, Dr. Dovec?" - Meet Michael Asike, MD, Gastroenterologist
Around GBMC
"What's Up, Dr. Dovec?" - Meet Jennifer Sullivan, MD, of Thoracic Surgery
Around GBMC
January 6: COVID-19 Update with President and CEO, John B. Chessare, MD, MPH
COVID-19
Computer Network Incident Update
Around GBMC
GBMC Health Partners at Padonia Grand Opening
Around GBMC